Related Experiment Video
Updated: Jun 26, 2026

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
Early predictors of nonadherence to antipsychotic therapy in first-episode psychosis
Mark Rabinovitch1, Laura Béchard-Evans, Norbert Schmitz
1Assistant Professor, Department of Psychiatry, McGill University, Douglas Hospital Research Centre, Montreal, Quebec.
Insights
Patients with first-episode psychosis (FEP) who have poor social support and family support are less likely to adhere to medication. Early acceptance of medication also predicts adherence in FEP treatment.
Area of Science:
- Psychiatry
- Clinical Psychology
- Pharmacology
Background:
- Medication adherence is crucial for managing first-episode psychosis (FEP).
- Factors influencing adherence in FEP patients require further investigation.
- Social and family support may play a role in treatment adherence.
Purpose of the Study:
- To test if poor social and family support at treatment initiation predicts nonadherence in the first 6 months of FEP treatment.
- To assess the independence of this association from other patient-related factors.
Main Methods:
- 100 patients with FEP were evaluated monthly for 6 months on medication adherence.
- Sociodemographic factors, illness characteristics, and social/family support were assessed.
- Univariate analyses and logistic regression were used to identify predictors of adherence.
Main Results:
- 54.9% of patients were adherent; 45.1% were nonadherent.
- Nonadherent patients had lower social support and were more likely to be single.
- Refusal of medication at the first offer was a strong predictor of nonadherence.
Conclusions:
- Social and family support are significant factors for early medication adherence in FEP.
- Early acceptance or rejection of medication strongly influences adherence.
- Interventions should consider social support and early medication engagement.
Objective:
To examine the hypothesis that poorer social and family support, identifiable at the onset of treatment, is associated with nonadherence in the first 6 months of treatment of patients with first-episode psychosis (FEP), independent of other patient-related factors.
Method:
Consecutive patients (n = 100) admitted to a specialized early intervention service for FEP who met the Diagnostic and Statistical Manual of Mental Disorders, fourth edition, criteria for either a schizophrenia spectrum disorder or an affective psychosis were evaluated monthly for 6 months regarding their adherence to medications. Using sociodemographic and illness-related factors, including social and family support, as independent variables and adherence as the dependent variable, univariate analyses were followed by logistic regression.
Results:
Fifty-six patients (54.9%) were adherent (76% to 100% of doses taken) and 46 (45.1%) nonadherent (less than 76% of doses taken). Nonadherent patients were less likely to have received a good level of social support (chi (2) = 5.89, df = 1, P = 0.02), as rated by their respective case manager, and more likely to be single (Fisher exact test, P = 0.019) and to have refused medication at the first offer of treatment (chi (2) = 19.70, df = 1, P = 0.001). Using logistic regression, both the level of social support (OR = 3.552, P = 0.03) and early medication acceptance (OR = 11.092, P < 0.001) were significant as predictors of adherence.
Conclusion:
These results suggest the significance of social and family support in achieving adherence to medications very early in the course of treatment of FEP, in addition to the influence of early acceptance or rejection of medication.
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Drug Therapy
Antianxiety Medications
Psychosis and Antipsychotic Drugs: Overview
Psychological and Sociocultural Causes of Schizophrenia
Antipsychotic Drugs: Typical and Atypical Agents
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
